Press Releases GoodRx Holdings, Inc.

Equities

GDRX

US38246G1085

Internet Services

Market Closed - Nasdaq Other stock markets 04:00:00 2026-05-14 pm EDT			5-day change	1st Jan Change
2.490 ^USD	-4.60%		-12.32%	-8.12%

May. 08	GoodRx Holdings, Inc., Q1 2026 Earnings Call, May 07, 2026
May. 06	GoodRx Holdings Q1 Adjusted Earnings, Revenue Fall	MT

Press Releases

May. 06	GoodRx Reports First Quarter 2026 Results	BU
May. 01	GoodRx Expands Offerings to Now Include Ozempic® Pill for Type 2 Diabetes Patients	BU
Apr. 20	GoodRx Announces Date for First Quarter 2026 Earnings Release and Conference Call	AQ
Apr. 17	GoodRx Announces Date for First Quarter 2026 Earnings Release and Conference Call	BU
Apr. 15	GoodRx Now Offers Access to Wegovy® HD at $399 Per Month Self-Pay Price	BU
Apr. 10	GoodRx Expands Access to Eli Lilly and Company's New Oral GLP-1, Foundayo, and Zepbound KwikPen with Self-Pay Pricing at More Than 70,000 Pharmacies Nationwide	AQ
Apr. 09	GoodRx Expands Access to Eli Lilly and Company’s New Oral GLP-1, Foundayo™, and Zepbound® KwikPen® with Self-Pay Pricing at More Than 70,000 Pharmacies Nationwide	BU
Mar. 11	GoodRx Partners with Viatris to Offer Up to 85% Savings on Established Brand Medications	BU
Mar. 06	GoodRx to Expand Employer-Sponsored Access to Zepbound® KwikPen®	BU
Feb. 25	GoodRx Reports Fourth Quarter and Full Year 2025 Results	BU
Feb. 24	GoodRx Expands Into Employer Market With Launch of “GoodRx Employer Direct”	BU
Feb. 06	US government launches TrumpRx, a platform for drug discounts	AQ
Feb. 05	GoodRx Powers Pricing for Leading Brand Medications on TrumpRx	BU
Feb. 02	GoodRx Earns HITRUST i1 Certification for the Second Consecutive Year, Reinforcing Its Commitment to Protecting Healthcare Data at Scale	BU
Jan. 28	GoodRx Announces Date for Fourth Quarter and Full Year 2025 Earnings Release and Conference Call	BU
Jan. 13	Surescripts and GoodRx Partner to Advance Patient Price Transparency	BU
Jan. 08	GoodRx Launches RxSmartSaver at Giant Eagle Pharmacies	BU
Jan. 05	GoodRx Now Offers Novo Nordisk’s Cash Price for the Launch of the Wegovy® Pill	BU
Dec. 16	GoodRx to Participate in the 44th Annual J.P. Morgan Healthcare Conference	BU
Nov. 17	GoodRx Launches New $39 Per Month Weight Loss Telemedicine Subscription, Unveils Industry-Leading Introductory Cash Price of $199 Per Month for Ozempic® and Wegovy®	BU
Nov. 04	GoodRx Reports Third Quarter 2025 Results	BU
25-10-15	GoodRx Launches New Hair Loss Subscription for Men to Simplify Access to Affordable Treatment	BU
25-10-08	GoodRx Announces Date for Third Quarter 2025 Earnings Release and Conference Call	BU
25-10-07	GoodRx Expands Affordable Access to Repatha with Nearly 60 Savings	AQ
25-10-06	GoodRx Expands Affordable Access to Repatha® with Nearly 60% Savings	BU